Skip to main content
Sudarshan Chemical Indus. Ltd. logo

Sudarshan Chemical Indus. Ltd. — Investor Relations & Filings

Ticker · SUDARSCHEM ISIN · INE659A01023 BSE.NS Manufacturing
Open in API
Filings indexed 2,134 across all filing types
Latest filing 2026-02-04 Board/Management Inform…
Country IN India
Listing BSE.NS SUDARSCHEM

About Sudarshan Chemical Indus. Ltd.

https://www.sudarshan.com/

Sudarshan Chemical Industries Ltd. is a global manufacturer of color and effect pigments, specializing in the production of organic, inorganic, and pearlescent pigments alongside pigment dispersions. The company provides a comprehensive portfolio of high-performance and classical pigments tailored for diverse applications in the coatings, plastics, printing inks, cosmetics, and textile sectors. Key product brands include Sudaperm, Sudafast, and Sumica, which are utilized for their specific coloristic properties and durability. With a strong emphasis on research and development, the company focuses on technical innovation and sustainable manufacturing processes to meet international quality standards. Its extensive distribution network supports a broad client base across multiple continents, offering customized coloring solutions and technical support for specialized industrial requirements.

Recent filings

Filing Released Lang Actions
Sudarshan Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Prior intimation ....
Board/Management Information Classification · 95% confidence The document is a letter dated 4th February 2026 addressed to stock exchanges informing about a scheduled Board Meeting on 12th February 2026 to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2025. It references compliance with SEBI Listing Regulations and insider trading regulations. The document does not contain any financial data or results itself but is an announcement of an upcoming board meeting where financial results will be approved and subsequently announced. The document length is short (2384 characters) and it serves as a notification rather than a report. Therefore, it fits the category of Board/Management Information (MANG) as it relates to board meeting scheduling and disclosures.
2026-02-04 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-04 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter dated 4th February 2026 addressed to stock exchanges informing about a scheduled Board Meeting on 12th February 2026 to consider and approve the unaudited financial results for the quarter and nine months ended 31st December 2025. It references regulatory compliance under SEBI Listing Regulations and insider trading regulations. The document does not contain the financial results themselves but is an announcement of the upcoming board meeting and the expected approval of financial results. The document length is short (2384 characters) and it does not include actual financial data or analysis. Therefore, it is not an Interim/Quarterly Report (IR) but rather an announcement related to the board meeting and financial results release. This fits the category of Regulatory Filings (RNS) as a general regulatory announcement and notification to exchanges about the board meeting and results approval schedule.
2026-02-04 English
Reply to Clarification- Financial results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding clarification on financial results filed for the quarter and year ended 31st March 2025. It discusses discrepancies in the EPS figures reported in XBRL filings versus quick results and mentions submission of a revised XBRL file. The document is short (2526 characters) and primarily serves as a clarification or regulatory communication about previously filed financial results rather than containing the financial results themselves. It does not contain comprehensive financial statements or substantive financial data but rather addresses a regulatory query about filings. Therefore, it fits best under Regulatory Filings (RNS) as a clarification letter related to financial disclosures.
2026-02-03 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation activities for the quarter ended 31st December 2025. It is a compliance certificate from the Registrar & Transfer Agent to the company and stock exchanges. The document is short (3338 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or any report publication. It is not an announcement of voting results, board changes, or capital changes. It is a regulatory filing related to securities dematerialisation compliance. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-01-06 English
Certificate under Reg 74(5) for the quarter ended 31st December 2025
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended 31st December 2025. It is a compliance certificate from the Registrar & Transfer Agent to the company and stock exchanges. The document is short (3338 characters) and primarily serves as a regulatory compliance confirmation rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed report content. It is not an announcement of a report but a certificate under a specific regulatory provision. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and regulatory confirmations.
2026-01-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.